Fortis Group Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
71,900
+26,917
+60% +$723K 0.4% 68
2026
Q1
$1.22M Buy
44,983
+14,355
+47% +$339K 0.2% 124
2025
Q4
$830K Sell
30,628
-74,707
-71% -$3.2M 0.14% 161
2025
Q3
$4.79M Buy
105,335
+49,205
+88% +$2.52M 0.82% 27
2025
Q2
$3.71M Buy
56,130
+21,648
+63% +$978K 0.67% 41
2025
Q1
$1.02M Buy
+34,482
New +$1.28M 0.2% 105

Other funds holding HIMS

Fortis Group Advisors's HIMS Position: Q2 2026 in Review

Fortis Group Advisors increased its Hims & Hers Health (HIMS) stake by 60% in Q2 2026, buying an estimated $723K and bringing the position to 71,900 shares worth $2.49M. The position accounts for 0.4% of the portfolio, ranked #68.

Fortis Group Advisors first reported a position in HIMS in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.79M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Fortis Group Advisors held 71,900 shares of Hims & Hers Health worth $2.49M as of Q2 2026.
  • Fortis Group Advisors bought 26,917 Hims & Hers Health shares in Q2 2026, an estimated $723K.
  • Hims & Hers Health made up 0.4% of Fortis Group Advisors's portfolio in Q2 2026, its #68 holding.
  • Fortis Group Advisors first reported a position in Hims & Hers Health in Q1 2025 and has held it in 6 quarters since.
  • Fortis Group Advisors's Hims & Hers Health position peaked at $4.79M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.